title: [Contrast medica nephropathy. Better understanding of risk markers and follow up needed].
authors.affiliation: Kliniken för njurmedicin och transplantation, Universitetssjukhuset, MAS, Malmö.
authors.forename: Gunnar
authors.initials: G
authors.lastname: Sterner
authors.forename: Mikael
authors.initials: M
authors.lastname: Hellström
authors.forename: Bo
authors.initials: B
authors.lastname: Lagerqvist
authors.forename: Peter
authors.initials: P
authors.lastname: Aspelin
authors.forename: Ulf
authors.initials: U
authors.lastname: Nyman
mesh_terms: D015415:Biomarkers / Q000032:analysis; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects*; D003404:Creatinine / Q000097:blood; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006801:Humans; D007456:Iodine Isotopes / Q000008:administration & dosage / Q000009:adverse effects; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control; D051437:Renal Insufficiency / Q000139:chemically induced / Q000517:prevention & control; D018570:Risk Assessment; D012307:Risk Factors; D012449:Safety
chemical_list: D015415:Biomarkers; D003287:Contrast Media; D007456:Iodine Isotopes; D003404:Creatinine